Barrow, Hanley, Mewhinney & Strauss’s Pediatrix Medical MD Stock Holding History
Bought
Maintained
Sold
Other funds holding MD
RCMNY
Barrow, Hanley, Mewhinney & Strauss's MD Position: Q4 2024 in Review
Barrow, Hanley, Mewhinney & Strauss sold out of Pediatrix Medical (MD) in Q4 2024, closing a stake of 1,032 shares — an estimated $12K sold.
Barrow, Hanley, Mewhinney & Strauss first reported a position in MD in Q3 2020 and held it in 17 quarters. The position peaked at $85K in Q4 2021. 229 funds tracked by Wall St. Rank hold MD as of Q4 2024.
- Barrow, Hanley, Mewhinney & Strauss reported no remaining Pediatrix Medical position as of Q4 2024 after selling out during the quarter.
- Barrow, Hanley, Mewhinney & Strauss sold 1,032 Pediatrix Medical shares in Q4 2024, an estimated $12K.
- Barrow, Hanley, Mewhinney & Strauss first reported a position in Pediatrix Medical in Q3 2020 and held it in 17 quarters.
- Barrow, Hanley, Mewhinney & Strauss's Pediatrix Medical position peaked at $85K in Q4 2021.
- 229 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2024.
Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q4 2024, filed 12 Feb 2025.